These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32860345)

  • 81. The new International League Against Epilepsy (ILAE) definition of Lennox-Gastaut syndrome: Practical implications and limitations.
    Asadi-Pooya AA
    J Clin Neurosci; 2023 Sep; 115():43-46. PubMed ID: 37481837
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
    Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
    J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD).
    Yasuhara A
    Brain Dev; 2010 Nov; 32(10):791-8. PubMed ID: 20826075
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
    Lo SH; Lloyd A; Marshall J; Vyas K
    Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome.
    Piña-Garza JE; Montouris GD; Vekeman F; Cheng WY; Tuttle E; Giguere-Duval P; Duh MS; Shen V; Saurer TB; Isojarvi J
    Epilepsy Behav; 2017 Aug; 73():46-50. PubMed ID: 28609734
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Optimal Target and Connectivity for Deep Brain Stimulation in Lennox-Gastaut Syndrome.
    Warren AEL; Dalic LJ; Bulluss KJ; BAppSci AR; Thevathasan W; Archer JS
    Ann Neurol; 2022 Jul; 92(1):61-74. PubMed ID: 35429045
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Brain network reconstruction of abnormal functional connectivity in Lennox-Gastaut syndrome according to drug responsiveness: A retrospective study.
    Park KM; Park S; Hur YJ
    Epilepsy Res; 2024 Feb; 200():107312. PubMed ID: 38309034
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Centromedian thalamic deep brain stimulation for drug-resistant epilepsy: single-center experience.
    Yang JC; Bullinger KL; Isbaine F; Alwaki A; Opri E; Willie JT; Gross RE
    J Neurosurg; 2022 Dec; 137(6):1591-1600. PubMed ID: 35395630
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder.
    Ko C; Kim N; Kim E; Song DH; Cheon KA
    Behav Brain Funct; 2016 Jun; 12(1):20. PubMed ID: 27350381
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Seizure outcome with responsive neurostimulation (RNS) comparing strip versus depth leads.
    Drees C; McDermott D; Sillau S; Abosch A; Ojemann S; Schwarz S; Brown MG
    Epilepsy Behav; 2020 Nov; 112():107402. PubMed ID: 32911300
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Thalamic responsive neurostimulation for the treatment of refractory epilepsy: an individual patient data meta-analysis.
    Bystrom LL; Levy AS; Brown EC; Fajardo M; Wang S
    J Neurosurg Pediatr; 2023 Sep; 32(3):366-375. PubMed ID: 37347644
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Paroxysmal fast activity is a biomarker of treatment response in deep brain stimulation for Lennox-Gastaut syndrome.
    Dalic LJ; Warren AEL; Spiegel C; Thevathasan W; Roten A; Bulluss KJ; Archer JS
    Epilepsia; 2022 Dec; 63(12):3134-3147. PubMed ID: 36114808
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rufinamide efficacy and association with phenotype and genotype in children with intractable epilepsy: A retrospective single center study.
    Oesch G; Bozarth XL
    Epilepsy Res; 2020 Dec; 168():106211. PubMed ID: 31575436
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Autism spectrum disorder and epilepsy: Disorders with a shared biology.
    Lee BH; Smith T; Paciorkowski AR
    Epilepsy Behav; 2015 Jun; 47():191-201. PubMed ID: 25900226
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rufinamide add-on therapy for drug-resistant epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Convulsive autism? Apropos of 9 cases of primary autism associated with the Lennox-Gastaut syndrome].
    Boyer JP; Deschatrette A; Delwarde M
    Pediatrie; 1981; 36(5):353-68. PubMed ID: 6793995
    [No Abstract]   [Full Text] [Related]  

  • 98. Targeting the centromedian thalamic nucleus for deep brain stimulation.
    Warren AEL; Dalic LJ; Thevathasan W; Roten A; Bulluss KJ; Archer J
    J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):339-349. PubMed ID: 31980515
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Endoscopic Total Corpus Callosotomy and Pan Commissurotomy for Lennox-Gastaut Syndrome.
    Doddamani R; Kota RC; Ahemad N; Chandra SP; Tripathi M
    Neurol India; 2022; 70(1):63-67. PubMed ID: 35263855
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Seizure freedom using a regional approach to responsive neurostimulation for multifocal drug-resistant epilepsy: illustrative case.
    Kimata AR; Collins SA; Asaad WF; Ayub N
    J Neurosurg Case Lessons; 2024 Oct; 8(15):. PubMed ID: 39378517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.